Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00245466
Status:
TERMINATED
Last Update Posted:
2011-05-20
First Post:
2005-10-26
Brief Title:
Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Organization Data
Organization:
Ferring Pharmaceuticals
Class:
INDUSTRY
Study ID:
FE200486 CS02A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ferring Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Clinical Development Support
Old Organization:
Ferring Pharmaceuticals